Literature DB >> 16775571

Beneficial effects of alkaline phosphatase in septic shock.

Fuhong Su1, Ruud Brands, Zhen Wang, Colin Verdant, Alejandro Bruhn, Ying Cai, Willem Raaben, Marty Wulferink, Jean-Louis Vincent.   

Abstract

OBJECTIVE: Alkaline phosphatase may decrease the harmful effects of lipopolysaccharide by detoxifying lipid A. The aim of this study was to investigate whether administration of alkaline phosphatase is beneficial in a clinically relevant septic shock model.
DESIGN: Interventional laboratory study.
SETTING: University hospital animal research laboratory.
SUBJECTS: Fourteen fasted, anesthetized, invasively monitored, mechanically ventilated, female sheep (27.6 +/- 3.9 kg).
INTERVENTIONS: Each animal received 1.5 g/kg body weight of feces intraperitoneally to induce sepsis. Ringer's lactate and a 6% hydroxyethyl starch solution were infused throughout the experiment to prevent hypovolemia. Two hours after feces injection, animals were randomized to alkaline phosphatase (60 units/kg intravenous bolus followed by a continuous infusion of 20 units/kg/hr for a total of 15 hrs) or no alkaline phosphatase (control group).
MEASUREMENTS AND MAIN RESULTS: All animals were studied until their spontaneous death or for a maximum of 30 hrs. Plasma alkaline phosphatase concentrations decreased in the control group but increased in the treatment group following alkaline phosphatase administration. In the treatment group, the Pao2/Fio2 ratio was higher (p < .05), blood interleukin-6 concentrations were lower (p < .05), and the survival time was longer (median time 23.8 vs. 17 .0 hrs, p < 0.05) than in the control group. There were no significant differences in systemic hemodynamics or diuresis.
CONCLUSIONS: In this clinically relevant septic shock model, alkaline phosphatase administration improved gas exchange, decreased interleukin-6 concentrations, and prolonged survival time.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775571     DOI: 10.1097/01.CCM.0000229887.70579.29

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  23 in total

1.  Clinical pharmacology of exogenously administered alkaline phosphatase.

Authors:  P Pickkers; F Snellen; P Rogiers; J Bakker; P Jorens; J Meulenbelt; H Spapen; J E Tulleken; R Lins; S Ramael; M Bulitta; J G van der Hoeven
Journal:  Eur J Clin Pharmacol       Date:  2008-12-02       Impact factor: 2.953

Review 2.  Intestinal alkaline phosphatase: a summary of its role in clinical disease.

Authors:  Jason Fawley; David M Gourlay
Journal:  J Surg Res       Date:  2015-12-17       Impact factor: 2.192

Review 3.  Pathogenesis of acute kidney injury: foundation for clinical practice.

Authors:  Gilbert R Kinsey; Mark D Okusa
Journal:  Am J Kidney Dis       Date:  2011-05-06       Impact factor: 8.860

Review 4.  Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.

Authors:  Allison L Brichacek; Candice M Brown
Journal:  Metab Brain Dis       Date:  2018-10-04       Impact factor: 3.584

5.  Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage.

Authors:  Constance M John; Nancy J Phillips; Richard Din; Mingfeng Liu; Einar Rosenqvist; E Arne Høiby; Daniel C Stein; Gary A Jarvis
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

6.  The enterocyte microvillus is a vesicle-generating organelle.

Authors:  Russell E McConnell; James N Higginbotham; David A Shifrin; David L Tabb; Robert J Coffey; Matthew J Tyska
Journal:  J Cell Biol       Date:  2009-06-29       Impact factor: 10.539

7.  Cerebral microcirculation is impaired during sepsis: an experimental study.

Authors:  Fabio Silvio Taccone; Fuhong Su; Charalampos Pierrakos; Xinrong He; Syril James; Olivier Dewitte; Jean-Louis Vincent; Daniel De Backer
Journal:  Crit Care       Date:  2010-07-28       Impact factor: 9.097

8.  Intestinal alkaline phosphatase prevents the systemic inflammatory response associated with necrotizing enterocolitis.

Authors:  Kevin M Riggle; Rebecca M Rentea; Scott R Welak; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay
Journal:  J Surg Res       Date:  2012-11-08       Impact factor: 2.192

9.  Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.

Authors:  Ruth Huizinga; Karim L Kreft; Sabina Onderwater; Joke G Boonstra; Ruud Brands; Rogier Q Hintzen; Jon D Laman
Journal:  J Neuroinflammation       Date:  2012-12-11       Impact factor: 8.322

Review 10.  Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantation.

Authors:  Petya Chernogorova; Robert Zeiser
Journal:  J Biomed Biotechnol       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.